Patent · US Active

Mitochondrion-bound nucleic acid for determining a health status of an individual

US9228226B2 · kind B2 · utility

0Cited by

3References

29Claims

0Family size

Assignees

Primagen Holding B.V. · NL
UMC Utrecht Holding B.V. · NL

Inventors

Maarten Penning · Angleur, BE
Henriette C. G. I. M. Maas · Amsterdam, NL
Marinus de Baar · Utrecht, NL
Emile Voest · Soest, NL

Key dates

Filing date	Dec 29, 2008
Grant date	Jan 5, 2016
Priority date	—
Expiry date	Feb 6, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/6865
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention describes means and methods for determining mitochondrion-bound nucleic acid and describes the use thereof in diagnostics. Preferable cell-free mitochondrion-bound nucleic acid is determined.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.